1-((2R,3R,4S,5S)-3,5-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione
Modify Date: 2024-02-01 20:47:28
1-((2R,3R,4S,5S)-3,5-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione structure
|
Common Name | 1-((2R,3R,4S,5S)-3,5-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | ||
|---|---|---|---|---|
| CAS Number | 1612841-22-1 | Molecular Weight | 264.18 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C9H10F2N2O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 1-((2R,3R,4S,5S)-3,5-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dioneHIV-1 inhibitor-3 is a HIV infection inhibitor extracted from patent US2018360927[1]. |
| Name | HIV-1 inhibitor-3 |
|---|---|
| Synonym | More Synonyms |
| Description | HIV-1 inhibitor-3 is a HIV infection inhibitor extracted from patent US2018360927[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Van Der, et al. ENZYMATIC REPLACEMENT THERAPY AND ANTISENSE THERAPY FOR POMPE DISEASE. |
| Molecular Formula | C9H10F2N2O5 |
|---|---|
| Molecular Weight | 264.18 |
| MFCD30471997 |